Oct 20, 5:43 PM ET
Danaher reported third-quarter 2026 sales of $6.6 billion, up 8.5% year over year, and net earnings of $1.2 billion, or $1.71 per diluted share, up 34.5%. Adjusted diluted EPS rose 11.5% to $2.11, and the company raised its full-year 2026 adjusted EPS guidance to $8.57-$8.62 from $8.45-$8.60. For shareholders, the results and higher guidance point to stronger profit, though core revenue growth excluding respiratory testing was 5.5%, and the company expects respiratory testing to be a headwind in the fourth quarter.
- Third-quarter net earnings were $1.2 billion, or $1.71 per diluted share, up 34.5% year over year.
- Adjusted diluted EPS was $2.11, up 11.5% from $1.89 a year earlier.
- Full-year 2026 adjusted diluted EPS guidance was raised to $8.57-$8.62 from $8.45-$8.60.
- Core revenue excluding respiratory testing rose 5.5%; total core revenue rose 3.0%.
Read the filing on SEC.gov ↗
Oct 13, 8:53 AM ET
Danaher's board increased its size to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg as directors effective October 9, 2026. Director Alan G. Spoon will retire from the board at the 2027 annual meeting, and founders Steven and Mitchell Rales waived 500,000-share RSU grants each for no consideration.
- Board increased to thirteen members; Daniel L. Comas and Robert M. Hershberg appointed effective October 9, 2026
- Comas, a former Danaher CFO, ended his consulting agreement effective September 30, 2026, after earning $393,750 in 2026 and $525,000 in 2025
- Alan G. Spoon will not stand for re-election and retires effective at the 2027 annual meeting; he cited no disagreement with the company
- Steven and Mitchell Rales each waived Founder RSUs covering 500,000 shares granted August 4, 2026, for no consideration
Read the filing on SEC.gov ↗
Aug 3, 4:27 PM ET
Danaher's board appointed Julie Sawyer Montgomery, currently Executive Vice President and head of the Diagnostics platform, as President and Chief Executive Officer effective October 1, 2026, and she joins the board at that time. Rainer Blair steps down as CEO and director and will serve as a senior advisor during the transition. The company said its third-quarter and full-year 2026 guidance is unchanged.
- Sawyer Montgomery's base salary as CEO is $1.5 million, with a target annual cash incentive of 200% of base salary.
- She will receive a special stock option award with a target value of $20 million, vesting 50% on the fourth and 50% on the fifth anniversary of the August 4, 2026 grant date.
- Blair will remain a senior advisor through December 31, 2026, then serve as a consultant until March 31, 2027, and is entitled to severance including 12 months of base salary.
- Danaher said there is no change to its previously communicated third-quarter and full-year 2026 guidance.
Read the filing on SEC.gov ↗
Jul 20, 5:55 PM ET
Danaher reported second-quarter 2026 revenue of $6.3 billion, up 5.5% year-over-year, and GAAP net earnings of $870 million, or $1.23 per diluted share, up 60%. The company raised its full-year 2026 adjusted diluted EPS guidance to $8.45-$8.60 from $8.35-$8.55, which points to higher expected per-share profit for shareholders.
- Q2 2026 adjusted diluted EPS was $1.94, up 8.0% year-over-year, and non-GAAP core revenue rose 3.0%.
- Full-year 2026 adjusted diluted EPS guidance rose to $8.45-$8.60 from $8.35-$8.55.
- Third-quarter 2026 core revenue growth is expected at 2.0% to 3.0%, and full-year core revenue growth at 3.0% to 4.0%.
- Operating cash flow was $1.5 billion and free cash flow was $1.3 billion in the quarter, and the Masimo acquisition closed earlier than anticipated.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.